References
- Park H, Park C, Kim Y, Rascati KL. Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis. Ann Pharmacother 2012; 46:1453–1469.
- Richard KR, Shelburne JS, Kirk JK. Tolerability of dipeptidyl peptidase-4 inhibitors: a review. Clin Ther 2011; 33:1609–1629.
- Neumiller JJ, Wood L, Campbell RK. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Pharmacotherapy 2010;30:463–484.
- Product information. Januvia (sitagliptin). Whitehouse Station, NJ: Merck and Co, April 2012.
- Product information. Onglyza (saxagliptin). Princeton, NJ: Bristol-Myers Squibb Co, April 2012.
- Product information. Tradjenta (linagliptin). Ridgefield, CT: Boehringer-Ingelheim, April 2012.
- Mikhail N. Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes. Curr Drug Saf 2011; 6:304–309.
- Williams-Herman D, Engel S, Round E, Johnson J, Golm GT, Guo H, et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord 2010; 10:7.
- American Association of Poison Control Centers (AAPCC) NPDS Annual Report Terminology. Available at: http://www.aapcc.org/dnn/NewsandEvents/NewsMediaResources/NPDSAnnualReportTerminology.aspx. Accessed on March 7, 2012.
- Furukawa S, Kumagi T, Miyake T, Ueda T, Niiya T, Nishino K, et al. Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and review of literature. Endocr J 2012; 59: 329–333.
- Toyoda-Akui M, Yokomori H, Kaneko F, Shimizu Y, Takeuchi H, Tahara K, et al. A case of drug-induced hepatic injury associated with sitagliptin. Intern Med 2011; 50:1015–1020.
- Whitney IJ, Borys DJ, Morgan DL. Incidence of hypoglycemia in sitagliptin overdose. (abstract). Clin Toxicol (Phila) 2009; 47: 736.
- Russell JL, Casavant MJ, Spiller HA, Mercurio-Zappala M, Huffman RM. An assessment of the potential toxicity of DPP-4 inhibitors. (abstract). Clin Toxicol (Phila) 2013; 51:657.
- McAuley D. DPP-4 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, Gliptins. Available at: http://www.globalrph.com/DPP-4-inhibitors.htm. Accessed on January 3, 2014.